Follow the Agarwal Toughened Glass India Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Agarwal Toughened Glass India Limited has published 3 insider filings. Market capitalisation: €156.2bn. The latest transaction was disclosed on 2 January 2026 (Purchase). Among the most active insiders: MAYUR AGARWAL. All data is free.
Analysts rate Agarwal Toughened Glass India Limited Buy (bullish), based on 5 analysts. Average price target: ₹545.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Agarwal Toughened Glass India Limited is a company specializing in the manufacturing of toughened glass, primarily for the healthcare and pharmaceutical sector. It is listed on the XBOM market.